about
The intron-22-inverted F8 locus permits factor VIII synthesis: explanation for low inhibitor risk and a role for pharmacogenomicsImmunogenicity assessment during the development of protein therapeutics.Peptides identified on monocyte-derived dendritic cells: a marker for clinical immunogenicity to FVIII productsMitigation of T-cell dependent immunogenicity by reengineering factor VIIa analogueEffects of codon optimization on coagulation factor IX translation and structure: Implications for protein and gene therapies
P50
description
researcher
@en
name
Zuben E Sauna
@en
type
label
Zuben E Sauna
@en
prefLabel
Zuben E Sauna
@en
P31
P496
0000-0001-8202-5188